Corrigendum to "A non-randomized phase 2 trial of pembrolizumab in untreated patients with carcinoma of unknown primary site" [Eur J Cancer (2026) 239 116709].
Saved in:
| Title: | Corrigendum to "A non-randomized phase 2 trial of pembrolizumab in untreated patients with carcinoma of unknown primary site" [Eur J Cancer (2026) 239 116709]. |
|---|---|
| Authors: | Monzon, Jose G.1 (AUTHOR) jose.monzon@albertahealthservices.ca, Karachiwala, Hatim1 (AUTHOR), Walker, John2 (AUTHOR), Goel, Rakesh3 (AUTHOR), Wheatley-Price, Paul3 (AUTHOR), Asmis, Timothy R.3 (AUTHOR), Navani, Vishal1 (AUTHOR), Tang, Patricia A.1 (AUTHOR), Vickers, Michael M.3 (AUTHOR) |
| Source: | European Journal of Cancer. Jun2026, Vol. 240, pN.PAG-N.PAG. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 193885810 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Corrigendum to "A non-randomized phase 2 trial of pembrolizumab in untreated patients with carcinoma of unknown primary site" [Eur J Cancer (2026) 239 116709]. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Monzon%2C+Jose+G%2E%22">Monzon, Jose G.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> jose.monzon@albertahealthservices.ca</i><br /><searchLink fieldCode="AR" term="%22Karachiwala%2C+Hatim%22">Karachiwala, Hatim</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Walker%2C+John%22">Walker, John</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Goel%2C+Rakesh%22">Goel, Rakesh</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wheatley-Price%2C+Paul%22">Wheatley-Price, Paul</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Asmis%2C+Timothy+R%2E%22">Asmis, Timothy R.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Navani%2C+Vishal%22">Navani, Vishal</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tang%2C+Patricia+A%2E%22">Tang, Patricia A.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Vickers%2C+Michael+M%2E%22">Vickers, Michael M.</searchLink><relatesTo>3</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22European+Journal+of+Cancer%22">European Journal of Cancer</searchLink>. Jun2026, Vol. 240, pN.PAG-N.PAG. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=193885810 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ejca.2026.116738 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: N.PAG Titles: – TitleFull: Corrigendum to "A non-randomized phase 2 trial of pembrolizumab in untreated patients with carcinoma of unknown primary site" [Eur J Cancer (2026) 239 116709]. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Monzon, Jose G. – PersonEntity: Name: NameFull: Karachiwala, Hatim – PersonEntity: Name: NameFull: Walker, John – PersonEntity: Name: NameFull: Goel, Rakesh – PersonEntity: Name: NameFull: Wheatley-Price, Paul – PersonEntity: Name: NameFull: Asmis, Timothy R. – PersonEntity: Name: NameFull: Navani, Vishal – PersonEntity: Name: NameFull: Tang, Patricia A. – PersonEntity: Name: NameFull: Vickers, Michael M. IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 06 Text: Jun2026 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 09598049 Numbering: – Type: volume Value: 240 Titles: – TitleFull: European Journal of Cancer Type: main |
| ResultId | 1 |